Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

liraglutide

Known as: N²?-(hexadecanoyl-gamma-glutamyle)-[34-arginine]GLP-1-(7-37)-peptide, Arg34Lys26-(N-?-(?-Glu(N-?-hexadecanoyl)))-GLP-1[7-37], N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glucagon-like-peptide-1-(7-37)-peptide 
A long-acting, fatty acylated glucagon-like peptide-1 (GLP-1) analog administered subcutaneously, with antihyperglycemic activity. Liraglutide's… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
BACKGROUND Glucagon-like peptide-1 (GLP-1) receptor agonists differ in their structure and duration of action and have been… Expand
Is this relevant?
Highly Cited
2016
Highly Cited
2016
BACKGROUND The cardiovascular effect of liraglutide, a glucagon-like peptide 1 analogue, when added to standard care in patients… Expand
  • table 2
Is this relevant?
Highly Cited
2016
Highly Cited
2016
  • John B. Buse
  • The New England journal of medicine
  • 2016
  • Corpus ID: 47255212
From the University of Texas Southwestern Medical Center, Dallas (S.P.M.); Massachusetts General Hospital, Boston (G.H.D.); Novo… Expand
  • table 2
Is this relevant?
Highly Cited
2015
Highly Cited
2015
BACKGROUND Obesity is a chronic disease with serious health consequences, but weight loss is difficult to maintain through… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Type 2 diabetes is a risk factor for Alzheimer's disease, most likely linked to an impairment of insulin signaling in the brain… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2009
Highly Cited
2009
BACKGROUND Unlike most antihyperglycaemic drugs, glucagon-like peptide-1 (GLP-1) receptor agonists have a glucose-dependent… Expand
Is this relevant?
Highly Cited
2009
Highly Cited
2009
OBJECTIVE—The efficacy and safety of adding liraglutide (a glucagon-like peptide-1 receptor agonist) to metformin were compared… Expand
  • table 1
  • figure 1
Is this relevant?
Highly Cited
2009
Highly Cited
2009
BACKGROUND New treatments for type 2 diabetes mellitus are needed to retain insulin-glucose coupling and lower the risk of weight… Expand
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Aims/hypothesisThe aim of the study was to compare the efficacy and safety of liraglutide in type 2 diabetes mellitus vs placebo… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Review
2006
Review
2006
Glucagon-like peptide 1 (GLP-1) is a gut-derived incretin hormone that stimulates insulin and suppresses glucagon secretion… Expand
  • figure 1
  • figure 2
  • figure 3
Is this relevant?